amooranin

N/A

Report date: 2025/01/26 16:55:57

NME

Base Information

Drug Nameamooranin

Drug Alias NameP-glycoprotein modulator (Dharma BioMedical)caspase-8 stimulator/apoptosis stimulator/cell cycle inhibitor (Dharma Biomedical)MCH-100XC2

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionP-glycoprotein 1 modulatorsCaspase-8 activators

TargetsCaspase-8P-glycoprotein 1

Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDharma Biomedical

China Registration ClassN/A

Develop Information

Active CompaniesDharma Biomedical

Inactive CompaniesN/A

Active IndicationsInflammationAutoimmune DiseasesNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A